Customer Service 1 (888) 261-2693
Please enter Search keyword. Advanced Search
Home About Us Resources Archive Free Reports Market Window

U.S. New Home Prices Hit a Record High... What's Next?

By Dr. Steve Sjuggerud
Tuesday, May 31, 2016

This week, new home prices in America hit a record high...
 
The median new home price in the U.S. is now $321,000.
 
The record high grabs the headlines... but the housing story right now is even more powerful than the headline alone suggests.
 
For example, new house prices are up 9.7% since last month – the biggest increase since 1992. And a lot of the numbers in the report from the U.S. Department of Commerce showed the best numbers since the peak of the housing market in 2007-2008.
 
So... is the housing boom over? Did you miss out on all the gains?
 
No, and no...
 
In short, the case for housing hasn't changed...
 
Mortgage rates are around 3.5% – near record lows. And the supply of new homes is low – there are enough to last 4.7 months at current sales levels. So the fundamental case for higher home prices is extremely solid. There's plenty of upside.
 
Beyond these housing-specific numbers, the bigger issue is this: Your mattress pays no interest.
 
Mom and Pop America earn next-to-zero percent interest on their money in the bank...
 
You can't retire on zero percent. You need to do something else with your money to live off of it in retirement.
 
Mom and Pop America need to buy a rental property and earn rent... or they need to buy dividend-paying stocks. Currently, they're doing neither.
 
That needs to change... because their mattress isn't about to start paying them interest.
 
Mom and Pop haven't bought a rental property or stocks yet. But they will.
 
We might be getting in the later innings of this housing boom that has lasted from 2011 to 2016. But there's still plenty of upside from here. There's plenty of money to be made in housing and stocks.
 
Take advantage of it now before it's too late...
 
Good investing,
 
Steve




Further Reading:

Investors are extremely worried about stocks today. And as Steve explained earlier this month, that means the market has plenty of upside left. Read more here: Stocks Reach a Hated Extreme... Big Gains Ahead.
 
"How bad will a rate hike be for your investments?" Steve writes. "The short answer is, you don't have anything to worry about. The longer answer is, we have an opportunity here." Get the full story here: What the Coming Interest-Rate Hike Means for Your Investments.

Market Notes


NEW HIGHS OF NOTE LAST WEEK
 
ExxonMobil (XOM)... oil giant
Lowe's (LOW)... home improvement
Burlington Stores (BURL)... discount stores
Dollar General (DG)... dollar stores
Dollar Tree (DLTR)... dollar stores
Aflac (AFL)... insurance
Alleghany (Y)... insurance
Chubb (CB)... insurance
Markel (MKL)... insurance
Marsh & McLennan (MMC)... insurance
Equifax (EFX)... credit reporting
TransUnion (TRU)... credit reporting
National Beverage (FIZZ)... soft drinks
DreamWorks Animation (DWA)... animated movies
Adobe Systems (ADBE)... software
Salesforce (CRM)... cloud computing
Nvidia (NVDA)... semiconductors
Texas Instruments (TXN)... electronics
Cintas (CTAS)... uniforms and supplies
Stanley Black & Decker (SWK)... tools
Toro (TTC)... lawn care
Valspar (VAL)... paint
WD-40 Company (WDFC)... consumer goods
Ritchie Bros. Auctioneers (RBA)... oil-equipment auctioneer
L-3 Communications (LLL)... "offense" contractor
 
NEW LOWS OF NOTE LAST WEEK
 
Twitter (TWTR)... social media
DSW (DSW)... retail
Express (EXPR)... retail
Foot Locker (FL)... retail
Guess (GES)... retail
America's Car-Mart (CRMT)... used cars

premium teaser

Two reasons we have NOT reached the peak in stocks...
 
It is the second-longest bull market in history... But you don't need to worry.
 

Recent Articles
Legal Notices: Stansberry Research LLC (Stansberry Research) is a publishing company and the indicators, strategies, reports, articles and all other features of our products are provided for informational and educational purposes only and should not be construed as personalized investment advice. Our recommendations and analysis are based on SEC filings, current events, interviews, corporate press releases, and what we've learned as financial journalists. It may contain errors and you shouldn't make any investment decision based solely on what you read here. It's your money and your responsibility.

 

Readers should be aware that trading stocks and all other financial instruments involves risk. Past performance is no guarantee of future results, and we make no representation that any customer will or is likely to achieve similar results.

 

Our testimonials are the words of real subscribers received in real letters, emails, and other feedback who have not been paid for their testimonials. Testimonials are printed under aliases to protect privacy, and edited for length. Their claims have not been independently verified or audited for accuracy. We do not know how much money was risked, what portion of their total portfolio was allocated, or how long they owned the security. We do not claim that the results experienced by such subscribers are typical and you will likely have different results.

 

Any performance results of our recommendations prepared by Stansberry Research are not based on actual trading of securities but are instead based on a hypothetical trading account. Hypothetical performance results have many inherent limitations. Your actual results may vary.

 

Stansberry Research expressly forbids its writers from having a financial interest in any security they recommend to our subscribers. And all Stansberry Research (and affiliated companies), employees, and agents must wait 24 hours after an initial trade recommendation is published on the Internet, or 72 hours after a direct mail publication is sent, before acting on that recommendation.

 

© 2024 Stansberry Research, LLC. | Privacy Policy| Customer Service
Stansberry Research. All Rights Reserved. Protected by copyright laws of the United States and international treaties. This website may only be used pursuant to the subscription agreement and any reproduction, copying, or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of Stansberry Research, LLC. 1125 N Charles St. Suite 500, Baltimore MD 21202.